Vishwajit Brahmbhatt, MD
Pain Medicine · Richmond, INNPI 1669406807
Payments from drug & device makers
Across 76 payments — averaging $19.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$254
- Medtronic$246
- Vertos Medical, Inc.$161
- Arbor Pharmaceuticals, Inc.$153
- Stryker$104
- Pacira Therapeutics, Inc.$73
- plus $484 from 20 others
What the payments were for
- Food & beverage$1,46399%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 20 | $254 |
| Medtronic(2 entities) | 10 | $246 |
| Vertos Medical, Inc. | 5 | $161 |
| Arbor Pharmaceuticals, Inc. | 5 | $153 |
| Stryker | 1 | $104 |
| Pacira Therapeutics, Inc. | 5 | $73 |
| Abbott | 2 | $53 |
| Daiichi Sankyo Inc. | 3 | $47 |
| Lilly USA, LLC | 2 | $45 |
| Pfizer | 3 | $38 |
| Si-bone, Inc. | 2 | $34 |
| Boston Scientific | 2 | $30 |
| Zyla Life Sciences, Inc. | 2 | $29 |
| Vertex | 1 | $28 |
| Biodelivery Sciences International, Inc. | 2 | $26 |
| Redhill Biopharma Inc. | 1 | $20 |
| Pernix Therapeutics Holdings, Inc. | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Bioventus LLC | 1 | $15 |
| Kaleo, Inc. | 1 | $14 |
| Convatec Inc. | 1 | $13 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Almatica Pharma LLC | 1 | $12 |
| Teva Pharmaceuticals USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- mild Device Kit$104
How this compares
$1,475 in reported general payments places this provider in the 35th percentile of 128 pain medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,339 | $30,690 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 995 | $19,676 |
| Oxycodone Hcl | 253 | $3,657 |
| Morphine Sulfate ErMorphine Sulfate | 144 | $3,429 |
| Gabapentin | 192 | $1,704 |
| Fentanyl | 20 | $1,275 |
| Tramadol Hcl | 120 | $1,035 |
| Carisoprodol | 33 | $984 |
| Pregabalin | 47 | $806 |
| Tizanidine Hcl | 73 | $673 |
| Morphine Sulfate | 22 | $545 |
| Hydromorphone Hcl | 25 | $389 |
| Baclofen | 33 | $331 |
| Ondansetron Hcl | 19 | $230 |
| Methylprednisolone | 37 | $173 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Richmond
- Joseph WilliamsonRichmond$6K
- Meredith LanghorstFishers$1.5M
- Derron WilsonCarmel$1.3M
- Jonathan GentileCarmel$1.1M
- Kevin MacadaegCarmel$866K
- Robert FunkCarmel$417K
- Andrew TrobridgeMuncie$266K
- Abhishek DasMishawaka$186K
- Rajiv TewariFishers$140K
- John SwoffordIndianapolis$127K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.